Cibus, Inc. (NASDAQ: CBUS)
$10.41
+0.0400 ( +0.39% ) 123.0K
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Market Data
Open
$10.41
Previous close
$10.37
Volume
123.0K
Market cap
$237.84M
Day range
$10.22 - $10.87
52 week range
$7.41 - $24.61
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Jun 03, 2024 |
4/a | Other | 1 | Jun 03, 2024 |
10-q | Quarterly Reports | 94 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
ars | Annual reports | 1 | Apr 19, 2024 |
def | Proxies and info statements | 19 | Apr 19, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
8-k | 8K-related | 14 | Mar 21, 2024 |
10-k | Annual reports | 128 | Mar 21, 2024 |
8-k | 8K-related | 14 | Mar 08, 2024 |